ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Acute abdomen,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
3,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3,3,Metastases to spinal cord,Metastases to specified sites,Metastases,Neopl,N
3,4,PIK3CA-activated mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
3,5,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,6,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
4,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
4,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5,5,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
6,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
6,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
6,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
7,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
7,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
7,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7,4,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
7,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
9,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
10,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
10,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
12,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
13,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
13,2,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
14,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
15,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
15,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
17,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
18,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
18,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,Y
19,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
20,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
20,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
20,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
21,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
22,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
22,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
24,1,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
24,2,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
25,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
26,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
26,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
27,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
28,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
29,1,Carbohydrate antigen 15-3 increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
29,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
29,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
30,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
30,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
31,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
31,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
31,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
32,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
32,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
32,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
32,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
32,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
32,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
32,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
32,8,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
32,9,Headache,Headaches NEC,Headaches,Nerv,N
32,10,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
32,11,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
32,12,Metastases to chest wall,Metastases to specified sites,Metastases,Neopl,N
32,13,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
32,14,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
32,15,Metastases to pancreas,Metastases to specified sites,Metastases,Neopl,N
32,16,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
32,17,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
32,18,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
32,19,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
32,20,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
32,21,Tumour marker increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
33,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
33,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
33,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
33,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
33,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
33,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
33,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
34,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
34,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
34,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
34,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
34,5,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
35,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
36,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
37,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
38,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
39,1,Body mass index increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
39,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
40,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
40,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
40,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
40,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
40,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
40,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
41,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
42,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
42,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
43,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
43,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
44,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
45,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
45,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
46,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
46,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
47,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
47,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
48,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
48,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
48,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
49,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
50,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
50,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
51,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
52,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
53,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
54,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
54,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
54,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
54,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
55,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
56,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
56,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
56,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
57,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
58,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
59,1,Ketoacidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
60,1,Vulvitis,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
61,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
62,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
62,2,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
62,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
62,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
62,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
63,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
63,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
63,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
64,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
65,1,Ketoacidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
66,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
66,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
67,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
68,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
69,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
69,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
70,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
70,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
70,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
70,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
71,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
72,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
72,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
72,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
73,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
74,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
75,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
76,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
77,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
78,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
79,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
80,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
81,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
82,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
83,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
84,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
85,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
85,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
86,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
86,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
87,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
88,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
89,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
90,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
90,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
90,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
90,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
90,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
91,1,Insulin resistance,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
92,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
92,2,Insulin resistance,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
93,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
93,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
94,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
94,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
94,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
94,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
94,5,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
94,6,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
94,7,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
94,8,Headache,Headaches NEC,Headaches,Nerv,N
94,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
94,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
94,11,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
94,12,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
94,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
94,14,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
94,15,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
95,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
95,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
95,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
95,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
95,5,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
95,6,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
95,7,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
95,8,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
95,9,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
95,10,Headache,Headaches NEC,Headaches,Nerv,N
95,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
95,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
95,13,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
95,14,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
95,15,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
95,16,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
95,17,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
95,18,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
96,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
97,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
98,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
99,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
